Congenital Central Hypoventilation Syndrome

Neurological Disorder MONDO:0800031 Pathograph 13 Show in embeddings browser Sleep Disorder Neurological Disease Congenital Disorder

Congenital central hypoventilation syndrome (historically Ondine's curse) is a rare disorder of autonomic control in which the automatic drive to breathe fails during sleep. The lesion is not in the lung, the chest wall, the airway, or the respiratory muscles: it is the loss of central chemoreception, so rising carbon dioxide and falling oxygen no longer generate a corrective ventilatory response, and breathing during sleep - which depends entirely on that automatic loop - becomes inadequate or ceases. Wakeful, cortically driven breathing is comparatively preserved, which is why affected infants can appear normal when awake and hypoventilate every time they fall asleep. Almost all cases are caused by de novo heterozygous mutation of PHOX2B, usually an expansion of a 20-residue polyalanine tract, and in mouse models the specific neuronal casualty is the retrotrapezoid nucleus - the principal central chemoreceptor site - with no other identified neuronal loss. Because PHOX2B is a master regulator of visceral reflex circuits generally, the disorder extends beyond breathing to a wider autonomic dysregulation, and to neural-crest derived complications: Hirschsprung disease and neuroblastic tumours. There is no treatment for the chemoreceptive lesion; management is lifelong assisted ventilation during sleep.

Ask OpenScientist

Ask a research question about Congenital Central Hypoventilation Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
5
Phenotypes
2
Gaps
13
Pathograph
1
Genes
4
Medical Actions
2
Subtypes
1
References
🏷

Classifications

Harrison's Part
NEUROLOGIC
👪

Inheritance

1
Autosomal dominant, usually de novo HP:0000006
Heterozygous mutation, dominant in effect, arising de novo in most cases - though "typically" rather than exclusively dominant: biallelic reduced-penetrance PHOX2B variants have been reported in two families. Somatic and germline mosaicism is present in 5-25% of asymptomatic parents, which has a counselling consequence that is easy to get wrong: a fetus must be considered at risk even when neither parent carries the proband's variant. Where a parent is a known heterozygote, sib risk is 50%. Once the familial variant is known, prenatal testing and preimplantation genetic testing are available.
Autosomal dominant inheritance
Show evidence (5 references)
PMID:12640453 SUPPORT Human Clinical
"We found heterozygous de novo mutations in PHOX2B in 18 of 29 individuals with CCHS."
Establishes the heterozygous, de novo pattern in the majority of cases.
PMID:23692929 SUPPORT Other
"Most cases are sporadic and caused by de novo PHOX2B gene mutations, which are usually polyalanine repeat expansions."
Independently confirms the sporadic, de novo pattern and the dominant mutation class.
PMID:20301600 SUPPORT Other
"CCHS is typically inherited in an autosomal dominant manner (CCHS caused by biallelic reduced penetrance PHOX2B pathogenic variants has been reported in two families)."
Cited as PARTIAL because it qualifies the dominant claim rather than simply supporting it: a biallelic reduced-penetrance route exists, reported in two families, so "autosomal dominant" is typical rather than exclusive.
+ 2 more references
◆

Subtypes

2
Neonatal-onset congenital central hypoventilation syndrome
Recognised in the first 30 days of life, and the more severe presentation. Hypoventilation with monotonous respiratory rates and shallow breathing, during sleep only or awake as well as asleep, together with the fuller autonomic picture: reduced heart-rate beat-to-beat variability, sinus pauses, altered thermoregulation, and altered pupillary light response. Neural-crest complications (Hirschsprung disease, oesophageal dysmotility, severe constipation, neuroblastic tumours) cluster here.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"Neonatal-onset CCHS is characterized by apparent hypoventilation with monotonous respiratory rates and shallow breathing either during sleep only or while awake as well as asleep; ANSD including decreased heart rate beat-to-beat variability and sinus pauses; altered temperature regulation; and..."
Defines the neonatal-onset presentation and its autonomic features, which is what separates it from the later-onset subtype below.
Later-onset congenital central hypoventilation syndrome
Less common, recognised from one month of age to adulthood, and attenuated: alveolar hypoventilation during sleep with milder autonomic manifestations. The subtype whose recognition depends on maintaining suspicion in unexplained hypoventilation, and the reason the phenotypic boundary of this disorder is still moving as PHOX2B testing spreads.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"Later-onset CCHS is characterized by alveolar hypoventilation during sleep and attenuated manifestations of ANSD."
Defines the later-onset subtype and its attenuated autonomic involvement.
?

Discussions and Knowledge Gaps

2
Why are retrotrapezoid nucleus neurons uniquely vulnerable to mutant PHOX2B when the protein is required throughout the visceral reflex circuitry?
KNOWLEDGE GAP gap_rtn_selective_vulnerability
Attached to
pathophysiology#Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons
This is the disorder's central unexplained fact and is stated as such in the primary literature. PHOX2B is expressed across the central and peripheral autonomic nervous system, yet in the mouse model carrying the commonest human mutation the retrotrapezoid nucleus is severely depleted and no other neuronal loss is detectable. Any account of the disorder that does not explain the selectivity is incomplete, and the question is not academic: the mutant protein is thought to act through polyalanine aggregation, and whether a therapy could rescue the vulnerable population depends on whether its vulnerability reflects a cell-intrinsic dependence on PHOX2B dosage, a developmental timing window, or a difference in aggregate handling.
Proposed experiments
Comparative single-cell profiling of vulnerable and spared PHOX2B lineages
exp_rtn_vulnerability_single_cell
Single-cell transcriptomic and proteomic comparison of retrotrapezoid nucleus neurons against spared PHOX2B-dependent populations in Phox2b(27Ala/+) and wild-type mice across the developmental window, quantifying PHOX2B target-gene dosage dependence and mutant-protein aggregate burden per lineage.
Can central chemoreception be restored pharmacologically, rather than only substituted for mechanically?
KNOWLEDGE GAP gap_no_therapy_for_chemoreflex
Attached to
pathophysiology#Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia
Every treatment curated in this entry acts downstream of the lesion, on ventilation rather than on chemoreception, and none is disease-modifying. Two lines have been proposed and neither is settled: desogestrel, a progestin observed to increase the ventilatory response in isolated cases and taken into clinical evaluation, and pharmacological approaches directed at the toxic effects of polyalanine-expanded PHOX2B aggregates. Both are curated here as open rather than as treatments, because the entry should not present investigational agents as options; the reason to record the gap is that a partial chemoreflex response would change the disorder's management fundamentally, and the conditional mouse model shows partial responses can develop.
Proposed experiments
Controlled assessment of progestin effect on the ventilatory response
exp_desogestrel_controlled_ventilatory_response
Blinded, placebo-controlled crossover assessment of the hypercapnic ventilatory response in adults with congenital central hypoventilation syndrome under desogestrel, with genotype stratification, since the published observations are uncontrolled and inconsistent across patients.
⚙

Pathophysiology

6
PHOX2B Polyalanine Expansion or Frameshift Mutation
The trigger. PHOX2B encodes a paired-like homeobox transcription factor that is a master regulator of visceral reflex circuit development. Heterozygous de novo mutation causes the disorder, and the mutation class is unusual: most are expansions of 5-9 alanines within a normal 20-residue polyalanine tract, probably arising by non-homologous recombination rather than by point mutation. The expansion length predicts phenotype severity closely enough that genotype guides clinical anticipation, which is why testing is diagnostic rather than confirmatory. A minority carry non-polyalanine repeat mutations - frameshift and missense - which produce more severe disease and a higher risk of the neural-crest tumour complications.
Downstream
Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons Mutant PHOX2B protein fails to support the development or survival of the retrotrapezoid nucleus neuronal population it normally specifies.
Generalised Autonomic Dysregulation and Neural Crest Complications PHOX2B is required for visceral reflex circuits and enteric and sympathoadrenal neural crest derivatives generally, so its disruption affects systems beyond respiratory control.
Show evidence (3 references)
PMID:12640453 SUPPORT Human Clinical
"We found heterozygous de novo mutations in PHOX2B in 18 of 29 individuals with CCHS."
The gene-discovery finding establishing PHOX2B mutation as the cause and its de novo, heterozygous character.
PMID:12640453 SUPPORT Human Clinical
"Most mutations consisted of 5-9 alanine expansions within a 20-residue polyalanine tract probably resulting from non-homologous recombination."
Defines the characteristic mutation class and its likely origin, which is what makes the genotype an interpretable severity predictor.
PMID:20208042 SUPPORT Other
"A PHOX2B mutation is required to confirm the diagnosis of CCHS. Knowledge of the specific PHOX2B mutation aids in anticipating the CCHS phenotype severity."
Establishes both the diagnostic requirement and the genotype-phenotype correlation on which clinical anticipation rests.
Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons
The mechanistically decisive step, and the reason this disorder is so informative about normal physiology. In mice carrying the commonest CCHS-causing mutation, the retrotrapezoid nucleus / parafacial respiratory group is severely depleted, and NO OTHER neuronal loss can be identified - an extraordinarily selective lesion for a transcription factor expressed throughout the visceral reflex circuitry. Those neurons are necessary for central chemoreception and for generating a normal respiratory rhythm at birth. The selectivity is itself unexplained: why this particular population should be uniquely vulnerable to mutant PHOX2B remains unknown, and it is the central open question of the disorder's cell biology.
retrotrapezoid nucleus chemoreceptor neuron CL:1000001 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves decreased retrotrapezoid nucleus chemoreceptor neuron, annotated with retrotrapezoid nucleus neuron (CL:1000001). CL:1000001 is a cell type from the Cell Ontology. ↓ DECREASED
retrotrapezoid nucleus UBERON:0009918 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in retrotrapezoid nucleus (UBERON:0009918). UBERON:0009918 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia Loss of the principal central chemoreceptor population abolishes the ventilatory response to rising carbon dioxide.
Show evidence (3 references)
PMID:19712905 SUPPORT Model Organism
"Neurons of the retrotrapezoïd nucleus/parafacial respiratory group (RTN/pFRG) were found severely depleted in these mice and no other neuronal loss could be identified."
Establishes both the identity of the lost population and the selectivity of the loss, which is what makes this node a specific lesion rather than a general developmental failure.
PMID:19712905 SUPPORT Model Organism
"Physiological experiments show that RTN/pFRG neurons are crucial to driving proper breathing at birth and are necessary for central chemoreception and the generation of a normal respiratory rhythm."
Establishes the functional necessity of the lost population, which is what links this node to the chemoreflex failure below it.
PMID:19712905 SUPPORT Model Organism
"To date, the reason for the selective vulnerability of RTN/pFRG neurons to PHOX2B protein dysfunction remains unexplained."
Cited as PARTIAL because it records the limit of the mechanism rather than supporting it: the selectivity is observed and unexplained, which is the open question named in the node description.
Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia
The central, disorder-defining physiological abnormality: rising arterial carbon dioxide and falling oxygen fail to produce the corrective increase in ventilation that they produce in everyone else. The defect is in the sensing and reflex limb, not in the effector - the lungs, chest wall, and respiratory muscles are normal and can be driven perfectly well, which is why mechanical ventilation works and why the disorder is compatible with normal life expectancy given adequate support. Patients characteristically do not experience dyspnoea during hypoventilation, because the sensation of air hunger depends on the same chemoreceptive input that is missing - a feature that makes the condition dangerous rather than merely limiting.
nervous system control of respiratory gas exchange GO:0002087 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased nervous system control of respiratory gas exchange, annotated with regulation of respiratory gaseous exchange by nervous system process (GO:0002087). GO:0002087 is a biological process from the Gene Ontology. ↓ DECREASED chemoreflex response to carbon dioxide GO:0010037 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased chemoreflex response to carbon dioxide, annotated with response to carbon dioxide (GO:0010037). GO:0010037 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Sleep-Dependent Alveolar Hypoventilation With the automatic chemoreflex lost, breathing during sleep - which depends on it - becomes inadequate, while wakeful cortically driven breathing is comparatively preserved.
Show evidence (2 references)
PMID:12640453 SUPPORT Human Clinical
"Congenital central hypoventilation syndrome (CCHS or Ondine's curse; OMIM 209880) is a life-threatening disorder involving an impaired ventilatory response to hypercarbia and hypoxemia."
Defines the disorder by exactly the failure this node encodes - an impaired ventilatory response to both chemical stimuli.
PMID:23692929 SUPPORT Other
"Congenital central hypoventilation syndrome (CCHS) is characterized by hypoventilation during sleep and impaired ventilatory responses to hypercapnia and hypoxemia."
Independently states the chemoreflex failure and pairs it with its state-dependent expression, which is the link to the node below.
Sleep-Dependent Alveolar Hypoventilation
The state dependence is the disorder's clinical signature and follows directly from how breathing is controlled. Wakefulness supplies a behavioural and cortical drive to breathe that is independent of chemoreception; sleep withdraws it, leaving the automatic chemoreflex loop alone in charge. Where that loop is absent, sleep produces progressive hypoventilation with hypercapnia and hypoxaemia, most severely in non-REM sleep, when chemoreceptive control normally dominates most completely. Severe cases hypoventilate when awake as well. Untreated, the consequence is cor pulmonale, hypoxic neurological injury, and death - the historical natural history that gave the disorder its Ondine's-curse name.
respiratory system process GO:0003016 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased respiratory system process (GO:0003016). GO:0003016 is a biological process from the Gene Ontology. ↓ DECREASED sleep GO:0030431 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves sleep (GO:0030431). GO:0030431 is a biological process from the Gene Ontology.
Downstream
Ventilator Dependence and Neurocognitive Risk Hypoventilation that cannot be corrected physiologically must be corrected mechanically, for life; residual and intermittent inadequacy of support threatens neurocognitive outcome.
Show evidence (2 references)
PMID:19712905 SUPPORT Other
"a rare disease defined by the lack of CO(2) responsiveness and of breathing automaticity in sleep"
States the state dependence explicitly - loss of breathing automaticity specifically in sleep - which is what this node encodes.
PMID:20208042 SUPPORT Other
"Congenital central hypoventilation syndrome (CCHS) is characterized by alveolar hypoventilation and autonomic dysregulation."
Pairs the alveolar hypoventilation of this node with the autonomic arm curated separately, which is how the policy statement frames the disorder.
Generalised Autonomic Dysregulation and Neural Crest Complications
A parallel arm arising directly from PHOX2B's broader role, and the reason this is a syndrome rather than a respiratory disease. Autonomic dysregulation affects multiple organ systems - cardiac rhythm with prolonged sinus pauses, thermoregulation, pupillary responses, oesophageal motility, sweating. Two neural-crest complications carry particular weight because they are genotype-linked and require active surveillance: Hirschsprung disease from failed enteric neural crest colonisation, and neuroblastic tumours (ganglioneuroma, neuroblastoma) from the sympathoadrenal lineage. The cardiac arm is the one that kills without warning, which is why 72-hour Holter monitoring is recommended as routine surveillance rather than as investigation of symptoms.
Downstream
Ventilator Dependence and Neurocognitive Risk Autonomic complications add to the overall burden of management and to the risk of sudden deterioration.
Show evidence (3 references)
PMID:12640453 SUPPORT Human Clinical
"This core phenotype is associated with lower-penetrance anomalies of the autonomic nervous system (ANS) including Hirschsprung disease and tumors of neural-crest derivatives such as ganglioneuromas and neuroblastomas."
Names the autonomic and neural-crest complications and records their lower penetrance relative to the respiratory core phenotype.
PMID:12640453 SUPPORT Human Clinical
"We show that PHOX2B is expressed in both the central and the peripheral ANS during human embryonic development."
Establishes the developmental expression pattern that explains why one transcription-factor mutation produces both the central respiratory and the peripheral autonomic arms.
PMID:20208042 SUPPORT Other
"(2) barium enema or manometry and/or full thickness rectal biopsy for patients with a history of constipation; and (3) imaging for neural crest tumors in individuals at greatest risk based on PHOX2B mutation."
Records the guideline's scheduled surveillance for the two neural-crest complications curated at this node, and that tumour imaging is directed by genotype rather than applied universally.
Ventilator Dependence and Neurocognitive Risk
The clinical endpoint. There is no therapy for the chemoreceptive lesion, so management is lifelong mechanical support of ventilation during sleep - positive-pressure ventilation via tracheostomy or mask, or bilateral phrenic nerve pacing for daytime support in those who also hypoventilate awake. The principal modifiable outcome is neurocognitive, and it depends on the adequacy of ventilation across all states and activities, which is why guideline management centres on repeated physiological assessment during every sleep stage and activity level rather than on a single titration.
Show evidence (2 references)
PMID:20208042 SUPPORT Other
"Recommended management options aimed toward maximizing safety and optimizing neurocognitive outcome"
States the two objectives of management, and specifically that neurocognitive outcome - not survival alone - is the target, which is what this node records.
PMID:20208042 SUPPORT Other
"physiologic studies during awake and asleep states to assess ventilatory needs during varying levels of activity and concentration, in all stages of sleep, with spontaneous breathing, and with artificial ventilation"
Specifies the state- and activity-dependent assessment the guideline requires, which is the operational consequence of the disorder's state dependence.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Congenital Central Hypoventilation Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Respiratory 1
Central Hypoventilation OBLIGATE HP:0007110 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Central hypoventilation (HP:0007110). HP:0007110 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20208042 SUPPORT Other
"Congenital central hypoventilation syndrome (CCHS) is characterized by alveolar hypoventilation and autonomic dysregulation."
OBLIGATE by definition: alveolar hypoventilation is the defining feature of the syndrome.
Other 4
Nocturnal Hypoventilation OBLIGATE HP:0002877 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nocturnal hypoventilation (HP:0002877), qualified as temporality nocturnal. HP:0002877 is a phenotype from the Human Phenotype Ontology.
Temporal: NOCTURNAL
Show evidence (1 reference)
PMID:23692929 SUPPORT Other
"Congenital central hypoventilation syndrome (CCHS) is characterized by hypoventilation during sleep and impaired ventilatory responses to hypercapnia and hypoxemia."
OBLIGATE by definition: sleep-related hypoventilation is a defining criterion of the disorder.
Hirschsprung Disease OCCASIONAL Aganglionic megacolon HP:0002251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aganglionic megacolon (HP:0002251). HP:0002251 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:12640453 SUPPORT Human Clinical
"This core phenotype is associated with lower-penetrance anomalies of the autonomic nervous system (ANS) including Hirschsprung disease"
The source describes these as lower-penetrance anomalies relative to the obligate respiratory core, which maps to the OCCASIONAL band; no exact percentage is quoted, so a tighter band is not asserted.
Neuroblastic Tumour OCCASIONAL Neuroblastic tumor HP:0004376 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neuroblastic tumor (HP:0004376). HP:0004376 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:12640453 SUPPORT Human Clinical
"tumors of neural-crest derivatives such as ganglioneuromas and neuroblastomas"
Named among the lower-penetrance associated anomalies, supporting the OCCASIONAL band on the same basis as Hirschsprung disease.
Autonomic Cardiac Dysregulation Decreased heart rate variability HP:0031861 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased heart rate variability (HP:0031861). HP:0031861 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20208042 SUPPORT Other
"evaluation of ANS dysregulation across all organ systems affected by the ANS"
Supports systematic autonomic dysregulation as a curated feature requiring evaluation; no frequency band is asserted, as the statement does not quantify the cardiac arm.
🧬

Genetic Associations

1
PHOX2B
Gene: PHOX2B hgnc:9143 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PHOX2B (hgnc:9143). hgnc:9143 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
PMID:12640453 SUPPORT Human Clinical
"Our data support an essential role of PHOX2B in the normal patterning of the autonomous ventilation system and, more generally, of the ANS in humans."
States the gene's causal role in both the respiratory and the wider autonomic arms of the phenotype.
PMID:20208042 SUPPORT Other
"Parents of patients with CCHS should be tested for PHOX2B mutations."
Supports the parental testing recommendation noted here, which follows from mosaicism and mild carrier states.
💊

Medical Actions

4
Lifelong Assisted Ventilation During Sleep
Action: Therapeutic ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Therapeutic Procedure (NCIT:C49236). NCIT:C49236 is a clinical intervention from the NCI Thesaurus. NCIT:C49236
The mainstay, and it is supportive rather than corrective: nothing addresses the chemoreceptive lesion, so ventilation is substituted for the absent automatic drive for life. Delivered by positive-pressure ventilation through tracheostomy (the standard in infancy and in severe disease) or by mask in older and milder patients. It acts on the hypoventilation node, downstream of the chemoreflex failure, which is why it restores gas exchange without restoring the sensation of air hunger or the ability to self-correct.
Mechanism Target:
INHIBITS Sleep-Dependent Alveolar Hypoventilation — Mechanically substitutes for the absent automatic ventilatory drive during sleep, correcting the gas-exchange consequence without acting on the chemoreceptive lesion.
Show evidence (1 reference)
PMID:20208042 SUPPORT Other
"to assess ventilatory needs during varying levels of activity and concentration, in all stages of sleep, with spontaneous breathing, and with artificial ventilation"
Establishes artificial ventilation as the assumed standard of care around which the entire management protocol is built.
Diaphragm Pacing by Phrenic Nerve Stimulation
Action: Therapeutic ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Therapeutic Procedure (NCIT:C49236). NCIT:C49236 is a clinical intervention from the NCI Thesaurus. NCIT:C49236
Bilateral phrenic nerve pacing drives the diaphragm directly, and is used principally to give ambulatory daytime support to patients who also hypoventilate awake - freeing them from a portable ventilator rather than replacing nocturnal support. Like positive-pressure ventilation it acts on the hypoventilation node and does nothing for the chemoreflex; unlike it, it requires an intact phrenic nerve and diaphragm, which the disorder spares.
Mechanism Target:
INHIBITS Sleep-Dependent Alveolar Hypoventilation — Electrically driven diaphragmatic contraction substitutes for absent automatic drive, principally to enable daytime mobility.
Show evidence (1 reference)
PMID:20208042 SUPPORT Other
"Recommended management options aimed toward maximizing safety and optimizing neurocognitive outcome include"
Cited as PARTIAL: the policy statement's abstract frames management around safety and neurocognitive outcome but does not enumerate diaphragm pacing among the listed recommendations, so this treatment is curated as an established option without abstract-level guideline endorsement.
Cardiac Pacemaker for Prolonged Asystole
Action: Therapeutic ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Therapeutic Procedure (NCIT:C49236). NCIT:C49236 is a clinical intervention from the NCI Thesaurus. NCIT:C49236
The autonomic arm of this disorder can kill independently of the respiratory arm. Prolonged transient asystoles - presenting as syncope or staring spells, and of significant duration (3.0 seconds or longer) - may warrant a cardiac pacemaker. This is why 72-hour Holter recording is scheduled surveillance rather than a response to symptoms: the threshold is a recorded pause duration, and the events are easily mistaken for seizures or dismissed as behavioural.
Mechanism Target:
BYPASSES Generalised Autonomic Dysregulation and Neural Crest Complications — Paces through the sinus pauses produced by autonomic dysregulation, supplying the impulse the failed reflex does not. It works around the lesion rather than blocking or decreasing it, which is why the effect is BYPASSES rather than INHIBITS.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"Prolonged transient asystoles that may present as syncope and/or staring spells and are of significant duration (≥3.0 seconds) may warrant placement of a cardiac pacemaker"
Gives both the indication and the duration threshold, which is what makes the Holter surveillance actionable.
Protective Eyewear
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Abnormal pupillary reactivity is part of the autonomic phenotype, and it has a practical consequence that is easy to overlook: with impaired pupillary constriction, ordinary daily light exposure - LED lighting, screens in school and work settings, mobile devices - is not attenuated normally, so protective eyewear may be needed. Curated because it is a genuine management item that follows from the autonomic node rather than the respiratory one.
Mechanism Target:
BYPASSES Generalised Autonomic Dysregulation and Neural Crest Complications — Attenuates incident light externally, standing in for the pupillary constriction the failed reflex does not provide. It does not restore or decrease the underlying dysregulation, so the effect is BYPASSES.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"abnormal pupillary reactivity may necessitate protective eye wear given the amount of light exposure in daily life from LED lights, and screen time in educational settings, computer-based work environments, and mobile devices"
States the indication and the everyday exposures that make it necessary.
🌍

Environmental Factors

3
Sedative, anaesthetic and other respiratory-depressant medications
exposure to sedative ECTO:9001748 Environmental Conditions, Treatments and Exposures Ontology (ECTO) Relation: this environmental factor is this exposure This environmental factor is exposure to sedative (ECTO:9001748). ECTO:9001748 is an exposure from the Environmental Conditions, Treatments and Exposures Ontology.
Prescription and non-prescription sedatives and anaesthetics, and recreational drugs, depress ventilation in a patient who has no chemoreflex with which to compensate. In an unaffected person a respiratory depressant is opposed by rising carbon dioxide driving increased ventilation; here that correction does not exist, so the depression is uncorrected and additive to an already inadequate baseline. This is the reason anaesthesia in this disorder is a planned event with ventilatory support arranged in advance rather than a routine one. Curated separately from the asphyxial circumstances below because the mechanism differs: this arm depresses respiratory drive, that one removes the opportunity for gas exchange.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"alcohol (respiratory depression), recreational drugs (varied effects including death), and prescription as well as non-prescription medications/sedatives/anesthetics that could induce respiratory depression"
Names the agents and the mechanism (respiratory depression) by which they act, which is what distinguishes this arm from the asphyxial one.
Mechanism Target:
EXACERBATES Sleep-Dependent Alveolar Hypoventilation — Pharmacological depression of respiratory drive adds to a deficit the patient cannot correct, because the chemoreflex that would normally oppose it is absent.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"medications/sedatives/anesthetics that could induce respiratory depression"
States the respiratory-depressant mechanism by which this exposure acts on the hypoventilation node.
Ethanol Exposure
exposure to ethanol ECTO:9000027 Environmental Conditions, Treatments and Exposures Ontology (ECTO) Relation: this environmental factor is this exposure This environmental factor is exposure to ethanol (ECTO:9000027). ECTO:9000027 is an exposure from the Environmental Conditions, Treatments and Exposures Ontology.
Named and bound for the chemical (ECTO:9000027, which involves CHEBI ethanol) rather than the drinking behaviour (ECTO:0001082) because the mechanism curated here is respiratory depression by ethanol acting on a brainstem with no chemoreflex to oppose it. Renamed from "Alcohol" so the binding is derivable from the entry's own name, following Esophageal_Carcinoma, HPV_Negative_Head_and_Neck_Cancer and Oral_Cavity_Squamous_Cell_Carcinoma. `just environmental-term-audit` suggests the behaviour term, because it matches on curator-written names rather than on the curated mechanism; that suggestion is advisory and is declined here for the same reason it was in those entries.
Called out separately in the GeneReviews avoid-list, and curated as its own exposure so the bound term matches what is claimed. Alcohol depresses respiration by the same route as the sedatives above, but it differs in exposure context: it is socially normal, self-administered, and typically taken without the medical supervision that surrounds an anaesthetic - which makes it the more likely of the two to be encountered unplanned by an adolescent or adult patient.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"alcohol (respiratory depression), recreational drugs (varied effects including death)"
Names alcohol and its mechanism (respiratory depression) in the source's own avoid-list. The quote runs on into recreational drugs because that is where the source's sentence ends; those are curated on the sedative entry above, not here.
Mechanism Target:
EXACERBATES Sleep-Dependent Alveolar Hypoventilation — Alcohol depresses respiratory drive in a patient with no chemoreflex to oppose it, so the depression is uncorrected.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"alcohol (respiratory depression), recreational drugs (varied effects including death)"
The source attributes respiratory depression to alcohol directly, which is the mechanism this link asserts.
Asphyxial circumstances (swimming, breath-holding contests)
No ECTO binding: the ontology has no term for voluntary breath-holding or for immersion-related asphyxial risk. ECTO was searched; left unbound rather than bound to an inaccurate near-match, per the no-term-beats-a-bad-one rule.
Swimming and breath-holding contests carry a risk of asphyxia and death, and the reason is specific to this disorder rather than general water safety: voluntary or immersion-imposed apnoea normally terminates when rising carbon dioxide produces an overwhelming urge to breathe. That urge is a chemoreflex percept, and these patients do not have it - so the protective endpoint that stops everyone else is missing, and breath-holding can continue to unconsciousness. Curated as its own exposure because it removes gas-exchange opportunity rather than depressing drive.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"Agents/circumstances to avoid: Swimming and breath-holding contests (risk of asphyxia, death)"
Names the circumstances and the stated consequence; the mechanistic reading in the description follows from the absent chemoreflex curated upstream.
Mechanism Target:
EXACERBATES Sleep-Dependent Alveolar Hypoventilation — Voluntary or immersion-imposed apnoea removes gas exchange in a patient with no chemoreflex-driven urge to breathe to terminate it.
Show evidence (1 reference)
PMID:20301600 SUPPORT Other
"Swimming and breath-holding contests (risk of asphyxia, death)"
Establishes the exposure and its consequence in the source's own terms.
🔬

Diagnosis

3
PHOX2B mutation testing
The confirmatory diagnostic test, and required for the diagnosis. Testing should include both the polyalanine repeat screen and sequencing for non-polyalanine mutations, since the latter carry different severity and tumour risk. Genotype also directs subsequent surveillance intensity.
Show evidence (2 references)
PMID:20208042 SUPPORT Other
"A PHOX2B mutation is required to confirm the diagnosis of CCHS."
States the diagnostic requirement directly.
PMID:20208042 SUPPORT Other
"Maintaining a high index of suspicion in cases of unexplained alveolar hypoventilation will likely identify a higher incidence of milder cases of CCHS."
Records that the phenotypic boundary is testing-dependent and expanding, which is why historical severity and prevalence figures describe the severe end of the spectrum.
Scheduled multisystem surveillance
Assessment every six months for the first three years, then annually. The schedule is multisystem because the disorder is, and several of its components look at things a respiratory follow-up would not: haemoglobin, haematocrit and reticulocyte count for polycythemia (the marrow's response to chronic hypoxaemia, and an index of whether ventilation is actually adequate); 72-hour Holter for abrupt prolonged asystoles; echocardiography for right ventricular hypertrophy and cor pulmonale; neurocognitive and educational assessment; and comprehensive age-appropriate non-invasive autonomic testing. Polycythemia and RVH are the two findings that reveal silently inadequate ventilation in a patient who cannot report dyspnoea.
Show evidence (2 references)
PMID:20301600 SUPPORT Other
"hemoglobin/hematocrit and reticulocyte count for polycythemia; (3) 72-hour Holter recording for abrupt, prolonged asystoles; (4) echocardiogram changes consistent with right ventricular hypertrophy and cor pulmonale; (5) neurocognitive assessment/educational needs; and (6) comprehensive..."
Enumerates the surveillance components beyond the respiratory assessment, which is what this diagnostic entry records.
PMID:20301600 SUPPORT Other
"Assess every six months for the first three years, then annually thereafter"
Gives the surveillance cadence.
State- and activity-resolved physiological assessment
Comprehensive in-hospital evaluation of ventilatory needs and responsiveness across wakefulness and all sleep stages, at varying activity and concentration levels, both spontaneously breathing and ventilated. Repeated biannually then annually. This is not a one-off titration: because the deficit is state-dependent, adequacy of support in one state says nothing about another.
Show evidence (1 reference)
PMID:20208042 SUPPORT Other
"biannual then annual in-hospital comprehensive evaluation"
Establishes the recommended assessment cadence, which underlies the repeated-evaluation point this diagnostic entry makes.
📊

Prevalence

1
Worldwide
Point Prevalence Ultra Rare
Consistently described as a rare disease; no reliable population rate is quoted in the sources curated here, and the denominator is in any case moving as PHOX2B testing identifies milder and later-onset cases. Recorded as a qualitative class rather than a fabricated rate.
Show evidence (1 reference)
PMID:19712905 SUPPORT Other
"a rare disease defined by the lack of CO(2) responsiveness and of breathing automaticity in sleep"
Supports the qualitative rarity class; no numeric rate is asserted because none is given.
{ }

Source YAML

click to show 
name: Congenital Central Hypoventilation Syndrome
creation_date: "2026-08-24T00:00:00Z"
category: Neurological Disorder
parents:
- Sleep Disorder
- Neurological Disease
- Congenital Disorder
disease_term:
  preferred_term: congenital central hypoventilation syndrome
  term:
    id: MONDO:0800031
    label: central hypoventilation syndrome, congenital
description: >-
  Congenital central hypoventilation syndrome (historically Ondine's curse) is a
  rare disorder of autonomic control in which the automatic drive to breathe
  fails during sleep. The lesion is not in the lung, the chest wall, the airway,
  or the respiratory muscles: it is the loss of central chemoreception, so
  rising carbon dioxide and falling oxygen no longer generate a corrective
  ventilatory response, and breathing during sleep - which depends entirely on
  that automatic loop - becomes inadequate or ceases. Wakeful, cortically driven
  breathing is comparatively preserved, which is why affected infants can appear
  normal when awake and hypoventilate every time they fall asleep. Almost all
  cases are caused by de novo heterozygous mutation of PHOX2B, usually an
  expansion of a 20-residue polyalanine tract, and in mouse models the specific
  neuronal casualty is the retrotrapezoid nucleus - the principal central
  chemoreceptor site - with no other identified neuronal loss. Because PHOX2B is
  a master regulator of visceral reflex circuits generally, the disorder extends
  beyond breathing to a wider autonomic dysregulation, and to neural-crest
  derived complications: Hirschsprung disease and neuroblastic tumours. There is
  no treatment for the chemoreceptive lesion; management is lifelong assisted
  ventilation during sleep.
notes: >-
  RELATIONSHIP TO sleep_disordered_breathing_intermittent_hypoxia, AND WHY THIS
  ENTRY CONFORMS ONLY IN PART. The entry conforms at the module's control-arm
  trigger, which explicitly covers the hyporesponsive (failed chemoreception)
  case as distinct from the unstable (high-loop-gain) case. It deliberately does
  NOT conform at the module's central node, #Chronic Intermittent Hypoxia and
  Reoxygenation: the gas-exchange lesion here is sustained nocturnal
  hypoventilation with hypercapnia, not cyclical desaturation followed by
  reoxygenation, and the module's notes name this disorder as the case that
  boundary exists for. The distinction is not pedantic - the reoxygenation phase
  is what generates the oxidative-inflammatory vascular arm in obstructive
  disease, and its absence here means the systemic consequences differ in kind,
  not merely in degree.

  DIAGNOSIS IS GENETIC, NOT PHYSIOLOGICAL. A PHOX2B mutation is required to
  confirm the diagnosis. This matters for curation because the phenotype's
  boundaries have moved: milder and later-onset cases are recognised as PHOX2B
  testing spreads, so historical prevalence and severity figures describe the
  severe end of a spectrum.
has_subtypes:
- name: Neonatal-onset CCHS
  display_name: Neonatal-onset congenital central hypoventilation syndrome
  description: >-
    Recognised in the first 30 days of life, and the more severe presentation.
    Hypoventilation with monotonous respiratory rates and shallow breathing,
    during sleep only or awake as well as asleep, together with the fuller
    autonomic picture: reduced heart-rate beat-to-beat variability, sinus
    pauses, altered thermoregulation, and altered pupillary light response.
    Neural-crest complications (Hirschsprung disease, oesophageal dysmotility,
    severe constipation, neuroblastic tumours) cluster here.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Neonatal-onset CCHS is characterized by apparent hypoventilation with
      monotonous respiratory rates and shallow breathing either during sleep only
      or while awake as well as asleep; ANSD including decreased heart rate
      beat-to-beat variability and sinus pauses; altered temperature regulation;
      and altered pupillary response to light.
    explanation: >-
      Defines the neonatal-onset presentation and its autonomic features, which
      is what separates it from the later-onset subtype below.
- name: Later-onset CCHS
  display_name: Later-onset congenital central hypoventilation syndrome
  description: >-
    Less common, recognised from one month of age to adulthood, and attenuated:
    alveolar hypoventilation during sleep with milder autonomic manifestations.
    The subtype whose recognition depends on maintaining suspicion in
    unexplained hypoventilation, and the reason the phenotypic boundary of this
    disorder is still moving as PHOX2B testing spreads.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Later-onset CCHS is characterized by alveolar hypoventilation during sleep
      and attenuated manifestations of ANSD.
    explanation: >-
      Defines the later-onset subtype and its attenuated autonomic involvement.
pathophysiology:
- name: PHOX2B Polyalanine Expansion or Frameshift Mutation
  description: >-
    The trigger. PHOX2B encodes a paired-like homeobox transcription factor that
    is a master regulator of visceral reflex circuit development. Heterozygous de
    novo mutation causes the disorder, and the mutation class is unusual: most
    are expansions of 5-9 alanines within a normal 20-residue polyalanine tract,
    probably arising by non-homologous recombination rather than by point
    mutation. The expansion length predicts phenotype severity closely enough
    that genotype guides clinical anticipation, which is why testing is
    diagnostic rather than confirmatory. A minority carry non-polyalanine
    repeat mutations - frameshift and missense - which produce more severe
    disease and a higher risk of the neural-crest tumour complications.
  role: trigger
  biological_scale: MOLECULAR
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found heterozygous de novo mutations in PHOX2B in 18 of 29 individuals
      with CCHS.
    explanation: >-
      The gene-discovery finding establishing PHOX2B mutation as the cause and
      its de novo, heterozygous character.
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most mutations consisted of 5-9 alanine expansions within a 20-residue
      polyalanine tract probably resulting from non-homologous recombination.
    explanation: >-
      Defines the characteristic mutation class and its likely origin, which is
      what makes the genotype an interpretable severity predictor.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A PHOX2B mutation is required to confirm the diagnosis of CCHS. Knowledge
      of the specific PHOX2B mutation aids in anticipating the CCHS phenotype
      severity.
    explanation: >-
      Establishes both the diagnostic requirement and the genotype-phenotype
      correlation on which clinical anticipation rests.
  downstream:
  - target: Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons
    description: >-
      Mutant PHOX2B protein fails to support the development or survival of the
      retrotrapezoid nucleus neuronal population it normally specifies.
    causal_link_type: DIRECT
  - target: Generalised Autonomic Dysregulation and Neural Crest Complications
    description: >-
      PHOX2B is required for visceral reflex circuits and enteric and
      sympathoadrenal neural crest derivatives generally, so its disruption
      affects systems beyond respiratory control.
    causal_link_type: DIRECT

- name: Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons
  description: >-
    The mechanistically decisive step, and the reason this disorder is so
    informative about normal physiology. In mice carrying the commonest
    CCHS-causing mutation, the retrotrapezoid nucleus / parafacial respiratory
    group is severely depleted, and NO OTHER neuronal loss can be identified -
    an extraordinarily selective lesion for a transcription factor expressed
    throughout the visceral reflex circuitry. Those neurons are necessary for
    central chemoreception and for generating a normal respiratory rhythm at
    birth. The selectivity is itself unexplained: why this particular population
    should be uniquely vulnerable to mutant PHOX2B remains unknown, and it is
    the central open question of the disorder's cell biology.
  role: amplifier
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: retrotrapezoid nucleus chemoreceptor neuron
    term:
      id: CL:1000001
      label: retrotrapezoid nucleus neuron
    modifier: DECREASED
  locations:
  - preferred_term: retrotrapezoid nucleus
    term:
      id: UBERON:0009918
      label: retrotrapezoid nucleus
  evidence:
  - reference: PMID:19712905
    reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Neurons of the retrotrapezoïd nucleus/parafacial respiratory group
      (RTN/pFRG) were found severely depleted in these mice and no other neuronal
      loss could be identified.
    explanation: >-
      Establishes both the identity of the lost population and the selectivity of
      the loss, which is what makes this node a specific lesion rather than a
      general developmental failure.
  - reference: PMID:19712905
    reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Physiological experiments show that RTN/pFRG neurons are crucial to driving
      proper breathing at birth and are necessary for central chemoreception and
      the generation of a normal respiratory rhythm.
    explanation: >-
      Establishes the functional necessity of the lost population, which is what
      links this node to the chemoreflex failure below it.
  - reference: PMID:19712905
    reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      To date, the reason for the selective vulnerability of RTN/pFRG neurons to
      PHOX2B protein dysfunction remains unexplained.
    explanation: >-
      Cited as PARTIAL because it records the limit of the mechanism rather than
      supporting it: the selectivity is observed and unexplained, which is the
      open question named in the node description.
  downstream:
  - target: Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia
    description: >-
      Loss of the principal central chemoreceptor population abolishes the
      ventilatory response to rising carbon dioxide.
    causal_link_type: DIRECT

- name: Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia
  description: >-
    The central, disorder-defining physiological abnormality: rising arterial
    carbon dioxide and falling oxygen fail to produce the corrective increase in
    ventilation that they produce in everyone else. The defect is in the sensing
    and reflex limb, not in the effector - the lungs, chest wall, and respiratory
    muscles are normal and can be driven perfectly well, which is why mechanical
    ventilation works and why the disorder is compatible with normal life
    expectancy given adequate support. Patients characteristically do not
    experience dyspnoea during hypoventilation, because the sensation of air
    hunger depends on the same chemoreceptive input that is missing - a feature
    that makes the condition dangerous rather than merely limiting.
  role: central_effector
  biological_scale: ORGANISM
  conforms_to: "sleep_disordered_breathing_intermittent_hypoxia#Ventilatory Control Instability or Chemoreflex Failure"
  biological_processes:
  - preferred_term: nervous system control of respiratory gas exchange
    term:
      id: GO:0002087
      label: regulation of respiratory gaseous exchange by nervous system process
    modifier: DECREASED
  - preferred_term: chemoreflex response to carbon dioxide
    term:
      id: GO:0010037
      label: response to carbon dioxide
    modifier: DECREASED
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital central hypoventilation syndrome (CCHS or Ondine's curse; OMIM
      209880) is a life-threatening disorder involving an impaired ventilatory
      response to hypercarbia and hypoxemia.
    explanation: >-
      Defines the disorder by exactly the failure this node encodes - an
      impaired ventilatory response to both chemical stimuli.
  - reference: PMID:23692929
    reference_title: Congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital central hypoventilation syndrome (CCHS) is characterized by
      hypoventilation during sleep and impaired ventilatory responses to
      hypercapnia and hypoxemia.
    explanation: >-
      Independently states the chemoreflex failure and pairs it with its
      state-dependent expression, which is the link to the node below.
  downstream:
  - target: Sleep-Dependent Alveolar Hypoventilation
    description: >-
      With the automatic chemoreflex lost, breathing during sleep - which depends
      on it - becomes inadequate, while wakeful cortically driven breathing is
      comparatively preserved.
    causal_link_type: DIRECT

- name: Sleep-Dependent Alveolar Hypoventilation
  description: >-
    The state dependence is the disorder's clinical signature and follows
    directly from how breathing is controlled. Wakefulness supplies a behavioural
    and cortical drive to breathe that is independent of chemoreception; sleep
    withdraws it, leaving the automatic chemoreflex loop alone in charge. Where
    that loop is absent, sleep produces progressive hypoventilation with
    hypercapnia and hypoxaemia, most severely in non-REM sleep, when
    chemoreceptive control normally dominates most completely. Severe cases
    hypoventilate when awake as well. Untreated, the consequence is cor
    pulmonale, hypoxic neurological injury, and death - the historical natural
    history that gave the disorder its Ondine's-curse name.
  role: effector
  biological_scale: ORGANISM
  biological_processes:
  - preferred_term: respiratory system process
    term:
      id: GO:0003016
      label: respiratory system process
    modifier: DECREASED
  - preferred_term: sleep
    term:
      id: GO:0030431
      label: sleep
  evidence:
  - reference: PMID:19712905
    reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      a rare disease defined by the lack of CO(2) responsiveness and of breathing
      automaticity in sleep
    explanation: >-
      States the state dependence explicitly - loss of breathing automaticity
      specifically in sleep - which is what this node encodes.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital central hypoventilation syndrome (CCHS) is characterized by
      alveolar hypoventilation and autonomic dysregulation.
    explanation: >-
      Pairs the alveolar hypoventilation of this node with the autonomic arm
      curated separately, which is how the policy statement frames the disorder.
  downstream:
  - target: Ventilator Dependence and Neurocognitive Risk
    description: >-
      Hypoventilation that cannot be corrected physiologically must be corrected
      mechanically, for life; residual and intermittent inadequacy of support
      threatens neurocognitive outcome.
    causal_link_type: DIRECT

- name: Generalised Autonomic Dysregulation and Neural Crest Complications
  description: >-
    A parallel arm arising directly from PHOX2B's broader role, and the reason
    this is a syndrome rather than a respiratory disease. Autonomic dysregulation
    affects multiple organ systems - cardiac rhythm with prolonged sinus pauses,
    thermoregulation, pupillary responses, oesophageal motility, sweating. Two
    neural-crest complications carry particular weight because they are
    genotype-linked and require active surveillance: Hirschsprung disease from
    failed enteric neural crest colonisation, and neuroblastic tumours
    (ganglioneuroma, neuroblastoma) from the sympathoadrenal lineage. The
    cardiac arm is the one that kills without warning, which is why 72-hour
    Holter monitoring is recommended as routine surveillance rather than as
    investigation of symptoms.
  role: effector
  biological_scale: ORGANISM
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This core phenotype is associated with lower-penetrance anomalies of the
      autonomic nervous system (ANS) including Hirschsprung disease and tumors of
      neural-crest derivatives such as ganglioneuromas and neuroblastomas.
    explanation: >-
      Names the autonomic and neural-crest complications and records their lower
      penetrance relative to the respiratory core phenotype.
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We show that PHOX2B is expressed in both the central and the peripheral ANS
      during human embryonic development.
    explanation: >-
      Establishes the developmental expression pattern that explains why one
      transcription-factor mutation produces both the central respiratory and the
      peripheral autonomic arms.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      (2) barium enema or manometry and/or full thickness rectal biopsy for
      patients with a history of constipation; and (3) imaging for neural crest
      tumors in individuals at greatest risk based on PHOX2B mutation.
    explanation: >-
      Records the guideline's scheduled surveillance for the two neural-crest
      complications curated at this node, and that tumour imaging is directed by
      genotype rather than applied universally.
  downstream:
  - target: Ventilator Dependence and Neurocognitive Risk
    description: >-
      Autonomic complications add to the overall burden of management and to the
      risk of sudden deterioration.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES

- name: Ventilator Dependence and Neurocognitive Risk
  description: >-
    The clinical endpoint. There is no therapy for the chemoreceptive lesion, so
    management is lifelong mechanical support of ventilation during sleep -
    positive-pressure ventilation via tracheostomy or mask, or bilateral phrenic
    nerve pacing for daytime support in those who also hypoventilate awake. The
    principal modifiable outcome is neurocognitive, and it depends on the
    adequacy of ventilation across all states and activities, which is why
    guideline management centres on repeated physiological assessment during
    every sleep stage and activity level rather than on a single titration.
  role: consequence
  biological_scale: ORGANISM
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Recommended management options aimed toward maximizing safety and
      optimizing neurocognitive outcome
    explanation: >-
      States the two objectives of management, and specifically that
      neurocognitive outcome - not survival alone - is the target, which is what
      this node records.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      physiologic studies during awake and asleep states to assess ventilatory
      needs during varying levels of activity and concentration, in all stages of
      sleep, with spontaneous breathing, and with artificial ventilation
    explanation: >-
      Specifies the state- and activity-dependent assessment the guideline
      requires, which is the operational consequence of the disorder's state
      dependence.
environmental:
- name: Sedative, anaesthetic and other respiratory-depressant medications
  description: >-
    Prescription and non-prescription sedatives and anaesthetics, and
    recreational drugs, depress ventilation in a patient who has no chemoreflex
    with which to compensate. In an unaffected person a respiratory depressant is
    opposed by rising carbon dioxide driving increased ventilation; here that
    correction does not exist, so the depression is uncorrected and additive to
    an already inadequate baseline. This is the reason anaesthesia in this
    disorder is a planned event with ventilatory support arranged in advance
    rather than a routine one. Curated separately from the asphyxial
    circumstances below because the mechanism differs: this arm depresses
    respiratory drive, that one removes the opportunity for gas exchange.
  exposure_term:
    preferred_term: exposure to sedative
    term:
      id: ECTO:9001748
      label: exposure to sedative
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      alcohol (respiratory depression), recreational drugs (varied effects
      including death), and prescription as well as non-prescription
      medications/sedatives/anesthetics that could induce respiratory depression
    explanation: >-
      Names the agents and the mechanism (respiratory depression) by which they
      act, which is what distinguishes this arm from the asphyxial one.
  influences_mechanisms:
  - target: Sleep-Dependent Alveolar Hypoventilation
    environmental_effect: EXACERBATES
    description: >-
      Pharmacological depression of respiratory drive adds to a deficit the
      patient cannot correct, because the chemoreflex that would normally oppose
      it is absent.
    evidence:
    - reference: PMID:20301600
      reference_title: Congenital Central Hypoventilation Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        medications/sedatives/anesthetics that could induce respiratory depression
      explanation: >-
        States the respiratory-depressant mechanism by which this exposure acts
        on the hypoventilation node.
- name: Ethanol Exposure
  description: >-
    Called out separately in the GeneReviews avoid-list, and curated as its own
    exposure so the bound term matches what is claimed. Alcohol depresses
    respiration by the same route as the sedatives above, but it differs in
    exposure context: it is socially normal, self-administered, and typically
    taken without the medical supervision that surrounds an anaesthetic - which
    makes it the more likely of the two to be encountered unplanned by an
    adolescent or adult patient.
  notes: >-
    Named and bound for the chemical (ECTO:9000027, which involves CHEBI ethanol)
    rather than the drinking behaviour (ECTO:0001082) because the mechanism curated
    here is respiratory depression by ethanol acting on a brainstem with no
    chemoreflex to oppose it. Renamed from "Alcohol" so the binding is derivable
    from the entry's own name, following Esophageal_Carcinoma,
    HPV_Negative_Head_and_Neck_Cancer and Oral_Cavity_Squamous_Cell_Carcinoma.
    `just environmental-term-audit` suggests the behaviour term, because it matches
    on curator-written names rather than on the curated mechanism; that suggestion
    is advisory and is declined here for the same reason it was in those entries.
  exposure_term:
    preferred_term: exposure to ethanol
    term:
      id: ECTO:9000027
      label: exposure to ethanol
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      alcohol (respiratory depression), recreational drugs (varied effects
      including death)
    explanation: >-
      Names alcohol and its mechanism (respiratory depression) in the source's
      own avoid-list. The quote runs on into recreational drugs because that is
      where the source's sentence ends; those are curated on the sedative entry
      above, not here.
  influences_mechanisms:
  - target: Sleep-Dependent Alveolar Hypoventilation
    environmental_effect: EXACERBATES
    description: >-
      Alcohol depresses respiratory drive in a patient with no chemoreflex to
      oppose it, so the depression is uncorrected.
    evidence:
    - reference: PMID:20301600
      reference_title: Congenital Central Hypoventilation Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        alcohol (respiratory depression), recreational drugs (varied effects
        including death)
      explanation: >-
        The source attributes respiratory depression to alcohol directly, which
        is the mechanism this link asserts.
- name: Asphyxial circumstances (swimming, breath-holding contests)
  description: >-
    Swimming and breath-holding contests carry a risk of asphyxia and death, and
    the reason is specific to this disorder rather than general water safety:
    voluntary or immersion-imposed apnoea normally terminates when rising carbon
    dioxide produces an overwhelming urge to breathe. That urge is a chemoreflex
    percept, and these patients do not have it - so the protective endpoint that
    stops everyone else is missing, and breath-holding can continue to
    unconsciousness. Curated as its own exposure because it removes gas-exchange
    opportunity rather than depressing drive.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Agents/circumstances to avoid: Swimming and breath-holding contests (risk
      of asphyxia, death)
    explanation: >-
      Names the circumstances and the stated consequence; the mechanistic reading
      in the description follows from the absent chemoreflex curated upstream.
  notes: >-
    No ECTO binding: the ontology has no term for voluntary breath-holding or for
    immersion-related asphyxial risk. ECTO was searched; left unbound rather than
    bound to an inaccurate near-match, per the no-term-beats-a-bad-one rule.
  influences_mechanisms:
  - target: Sleep-Dependent Alveolar Hypoventilation
    environmental_effect: EXACERBATES
    description: >-
      Voluntary or immersion-imposed apnoea removes gas exchange in a patient
      with no chemoreflex-driven urge to breathe to terminate it.
    evidence:
    - reference: PMID:20301600
      reference_title: Congenital Central Hypoventilation Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Swimming and breath-holding contests (risk of asphyxia, death)
      explanation: >-
        Establishes the exposure and its consequence in the source's own terms.
phenotypes:
- category: Respiratory
  name: Central Hypoventilation
  description: >-
    Inadequate alveolar ventilation from absent central respiratory drive rather
    than from any mechanical or pulmonary limitation, with hypercapnia and
    hypoxaemia and characteristically without dyspnoea.
  phenotype_term:
    preferred_term: Central hypoventilation
    term:
      id: HP:0007110
      label: Central hypoventilation
  frequency: OBLIGATE
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital central hypoventilation syndrome (CCHS) is characterized by
      alveolar hypoventilation and autonomic dysregulation.
    explanation: >-
      OBLIGATE by definition: alveolar hypoventilation is the defining feature of
      the syndrome.
- category: Respiratory
  name: Nocturnal Hypoventilation
  description: >-
    Hypoventilation that is present or markedly worse during sleep, reflecting
    withdrawal of the wakefulness drive to breathe and leaving the absent
    chemoreflex in sole control.
  phenotype_term:
    preferred_term: Nocturnal hypoventilation
    term:
      id: HP:0002877
      label: Nocturnal hypoventilation
    temporality: NOCTURNAL
  frequency: OBLIGATE
  evidence:
  - reference: PMID:23692929
    reference_title: Congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital central hypoventilation syndrome (CCHS) is characterized by
      hypoventilation during sleep and impaired ventilatory responses to
      hypercapnia and hypoxemia.
    explanation: >-
      OBLIGATE by definition: sleep-related hypoventilation is a defining
      criterion of the disorder.
- category: Gastrointestinal
  name: Hirschsprung Disease
  description: >-
    Aganglionic megacolon from failed enteric neural crest colonisation,
    occurring in a minority (the CCHS-Hirschsprung combination is also called
    Haddad syndrome) and more common with non-polyalanine repeat mutations.
  phenotype_term:
    preferred_term: Aganglionic megacolon
    term:
      id: HP:0002251
      label: Aganglionic megacolon
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This core phenotype is associated with lower-penetrance anomalies of the
      autonomic nervous system (ANS) including Hirschsprung disease
    explanation: >-
      The source describes these as lower-penetrance anomalies relative to the
      obligate respiratory core, which maps to the OCCASIONAL band; no exact
      percentage is quoted, so a tighter band is not asserted.
- category: Oncological
  name: Neuroblastic Tumour
  description: >-
    Tumours of sympathoadrenal neural crest derivatives - ganglioneuroma,
    ganglioneuroblastoma, neuroblastoma - occurring in a minority and
    concentrated in specific PHOX2B genotypes, which is why the guideline
    recommends tumour imaging targeted by mutation rather than universally.
  phenotype_term:
    preferred_term: Neuroblastic tumor
    term:
      id: HP:0004376
      label: Neuroblastic tumor
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      tumors of neural-crest derivatives such as ganglioneuromas and
      neuroblastomas
    explanation: >-
      Named among the lower-penetrance associated anomalies, supporting the
      OCCASIONAL band on the same basis as Hirschsprung disease.
- category: Cardiovascular
  name: Autonomic Cardiac Dysregulation
  description: >-
    Reduced heart rate variability and prolonged sinus pauses, which may be
    asymptomatic until they cause syncope or sudden death - the reason
    surveillance Holter monitoring is recommended.
  phenotype_term:
    preferred_term: Decreased heart rate variability
    term:
      id: HP:0031861
      label: Decreased heart rate variability
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      evaluation of ANS dysregulation across all organ systems affected by the ANS
    explanation: >-
      Supports systematic autonomic dysregulation as a curated feature requiring
      evaluation; no frequency band is asserted, as the statement does not
      quantify the cardiac arm.
genetic:
- name: PHOX2B
  notes: >-
    Paired-like homeobox transcription factor and master regulator of visceral
    reflex circuits. Heterozygous de novo mutation causes essentially all
    congenital central hypoventilation syndrome. Most mutations are expansions of
    5-9 alanines within a 20-residue polyalanine tract; expansion length
    correlates with severity closely enough to guide clinical anticipation.
    Non-polyalanine repeat mutations (frameshift, missense) produce more severe
    disease with greater neural-crest tumour risk. Parents should be tested,
    since mosaicism and mildly affected carriers occur.
  gene_term:
    preferred_term: PHOX2B
    term:
      id: hgnc:9143
      label: PHOX2B
  relationship_type: CAUSATIVE
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our data support an essential role of PHOX2B in the normal patterning of
      the autonomous ventilation system and, more generally, of the ANS in humans.
    explanation: >-
      States the gene's causal role in both the respiratory and the wider
      autonomic arms of the phenotype.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Parents of patients with CCHS should be tested for PHOX2B mutations.
    explanation: >-
      Supports the parental testing recommendation noted here, which follows
      from mosaicism and mild carrier states.
inheritance:
- name: Autosomal dominant, usually de novo
  description: >-
    Heterozygous mutation, dominant in effect, arising de novo in most cases -
    though "typically" rather than exclusively dominant: biallelic
    reduced-penetrance PHOX2B variants have been reported in two families.
    Somatic and germline mosaicism is present in 5-25% of asymptomatic parents,
    which has a counselling consequence that is easy to get wrong: a fetus must
    be considered at risk even when neither parent carries the proband's
    variant. Where a parent is a known heterozygote, sib risk is 50%. Once the
    familial variant is known, prenatal testing and preimplantation genetic
    testing are available.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:12640453
    reference_title: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found heterozygous de novo mutations in PHOX2B in 18 of 29 individuals
      with CCHS.
    explanation: >-
      Establishes the heterozygous, de novo pattern in the majority of cases.
  - reference: PMID:23692929
    reference_title: Congenital central hypoventilation syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Most cases are sporadic and caused by de novo PHOX2B gene mutations, which
      are usually polyalanine repeat expansions.
    explanation: >-
      Independently confirms the sporadic, de novo pattern and the dominant
      mutation class.
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      CCHS is typically inherited in an autosomal dominant manner (CCHS caused by
      biallelic reduced penetrance PHOX2B pathogenic variants has been reported
      in two families).
    explanation: >-
      Cited as PARTIAL because it qualifies the dominant claim rather than simply
      supporting it: a biallelic reduced-penetrance route exists, reported in two
      families, so "autosomal dominant" is typical rather than exclusive.
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Somatic/germline mosaicism is present in 5%-25% of asymptomatic parents.
    explanation: >-
      Quantifies parental mosaicism, which is the reason parental testing is
      recommended and the reason a negative parental test does not reduce fetal
      risk to background - see the recurrence-risk note in this block.
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      because of the high frequency of parental mosaicism in CCHS, a fetus should
      be considered at risk for CCHS even if the PHOX2B pathogenic variant
      detected in the proband was not identified in either parent
    explanation: >-
      The counselling consequence of the mosaicism rate, and the single most
      consequential statement in this block: a reassuring parental result does
      not make a subsequent pregnancy low-risk.
diagnosis:
- name: PHOX2B mutation testing
  description: >-
    The confirmatory diagnostic test, and required for the diagnosis. Testing
    should include both the polyalanine repeat screen and sequencing for
    non-polyalanine mutations, since the latter carry different severity and
    tumour risk. Genotype also directs subsequent surveillance intensity.
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A PHOX2B mutation is required to confirm the diagnosis of CCHS.
    explanation: >-
      States the diagnostic requirement directly.
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Maintaining a high index of suspicion in cases of unexplained alveolar
      hypoventilation will likely identify a higher incidence of milder cases of
      CCHS.
    explanation: >-
      Records that the phenotypic boundary is testing-dependent and expanding,
      which is why historical severity and prevalence figures describe the severe
      end of the spectrum.
- name: Scheduled multisystem surveillance
  description: >-
    Assessment every six months for the first three years, then annually. The
    schedule is multisystem because the disorder is, and several of its
    components look at things a respiratory follow-up would not: haemoglobin,
    haematocrit and reticulocyte count for polycythemia (the marrow's response
    to chronic hypoxaemia, and an index of whether ventilation is actually
    adequate); 72-hour Holter for abrupt prolonged asystoles; echocardiography
    for right ventricular hypertrophy and cor pulmonale; neurocognitive and
    educational assessment; and comprehensive age-appropriate non-invasive
    autonomic testing. Polycythemia and RVH are the two findings that reveal
    silently inadequate ventilation in a patient who cannot report dyspnoea.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      hemoglobin/hematocrit and reticulocyte count for polycythemia; (3) 72-hour
      Holter recording for abrupt, prolonged asystoles; (4) echocardiogram changes
      consistent with right ventricular hypertrophy and cor pulmonale; (5)
      neurocognitive assessment/educational needs; and (6) comprehensive
      age-appropriate noninvasive autonomic testing
    explanation: >-
      Enumerates the surveillance components beyond the respiratory assessment,
      which is what this diagnostic entry records.
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Assess every six months for the first three years, then annually thereafter
    explanation: >-
      Gives the surveillance cadence.
- name: State- and activity-resolved physiological assessment
  description: >-
    Comprehensive in-hospital evaluation of ventilatory needs and responsiveness
    across wakefulness and all sleep stages, at varying activity and
    concentration levels, both spontaneously breathing and ventilated. Repeated
    biannually then annually. This is not a one-off titration: because the
    deficit is state-dependent, adequacy of support in one state says nothing
    about another.
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      biannual then annual in-hospital comprehensive evaluation
    explanation: >-
      Establishes the recommended assessment cadence, which underlies the
      repeated-evaluation point this diagnostic entry makes.
treatments:
- name: Lifelong Assisted Ventilation During Sleep
  description: >-
    The mainstay, and it is supportive rather than corrective: nothing addresses
    the chemoreceptive lesion, so ventilation is substituted for the absent
    automatic drive for life. Delivered by positive-pressure ventilation through
    tracheostomy (the standard in infancy and in severe disease) or by mask in
    older and milder patients. It acts on the hypoventilation node, downstream of
    the chemoreflex failure, which is why it restores gas exchange without
    restoring the sensation of air hunger or the ability to self-correct.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  target_mechanisms:
  - target: Sleep-Dependent Alveolar Hypoventilation
    treatment_effect: INHIBITS
    description: >-
      Mechanically substitutes for the absent automatic ventilatory drive during
      sleep, correcting the gas-exchange consequence without acting on the
      chemoreceptive lesion.
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      to assess ventilatory needs during varying levels of activity and
      concentration, in all stages of sleep, with spontaneous breathing, and with
      artificial ventilation
    explanation: >-
      Establishes artificial ventilation as the assumed standard of care around
      which the entire management protocol is built.
- name: Diaphragm Pacing by Phrenic Nerve Stimulation
  description: >-
    Bilateral phrenic nerve pacing drives the diaphragm directly, and is used
    principally to give ambulatory daytime support to patients who also
    hypoventilate awake - freeing them from a portable ventilator rather than
    replacing nocturnal support. Like positive-pressure ventilation it acts on
    the hypoventilation node and does nothing for the chemoreflex; unlike it, it
    requires an intact phrenic nerve and diaphragm, which the disorder spares.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  target_mechanisms:
  - target: Sleep-Dependent Alveolar Hypoventilation
    treatment_effect: INHIBITS
    description: >-
      Electrically driven diaphragmatic contraction substitutes for absent
      automatic drive, principally to enable daytime mobility.
  evidence:
  - reference: PMID:20208042
    reference_title: "An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Recommended management options aimed toward maximizing safety and
      optimizing neurocognitive outcome include
    explanation: >-
      Cited as PARTIAL: the policy statement's abstract frames management around
      safety and neurocognitive outcome but does not enumerate diaphragm pacing
      among the listed recommendations, so this treatment is curated as an
      established option without abstract-level guideline endorsement.
- name: Cardiac Pacemaker for Prolonged Asystole
  description: >-
    The autonomic arm of this disorder can kill independently of the respiratory
    arm. Prolonged transient asystoles - presenting as syncope or staring spells,
    and of significant duration (3.0 seconds or longer) - may warrant a cardiac
    pacemaker. This is why 72-hour Holter recording is scheduled surveillance
    rather than a response to symptoms: the threshold is a recorded pause
    duration, and the events are easily mistaken for seizures or dismissed as
    behavioural.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  target_mechanisms:
  - target: Generalised Autonomic Dysregulation and Neural Crest Complications
    treatment_effect: BYPASSES
    description: >-
      Paces through the sinus pauses produced by autonomic dysregulation,
      supplying the impulse the failed reflex does not. It works around the
      lesion rather than blocking or decreasing it, which is why the effect is
      BYPASSES rather than INHIBITS.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Prolonged transient asystoles that may present as syncope and/or staring
      spells and are of significant duration (≥3.0 seconds) may warrant placement
      of a cardiac pacemaker
    explanation: >-
      Gives both the indication and the duration threshold, which is what makes
      the Holter surveillance actionable.
- name: Protective Eyewear
  description: >-
    Abnormal pupillary reactivity is part of the autonomic phenotype, and it has
    a practical consequence that is easy to overlook: with impaired pupillary
    constriction, ordinary daily light exposure - LED lighting, screens in
    school and work settings, mobile devices - is not attenuated normally, so
    protective eyewear may be needed. Curated because it is a genuine management
    item that follows from the autonomic node rather than the respiratory one.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Generalised Autonomic Dysregulation and Neural Crest Complications
    treatment_effect: BYPASSES
    description: >-
      Attenuates incident light externally, standing in for the pupillary
      constriction the failed reflex does not provide. It does not restore or
      decrease the underlying dysregulation, so the effect is BYPASSES.
  evidence:
  - reference: PMID:20301600
    reference_title: Congenital Central Hypoventilation Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      abnormal pupillary reactivity may necessitate protective eye wear given the
      amount of light exposure in daily life from LED lights, and screen time in
      educational settings, computer-based work environments, and mobile devices
    explanation: >-
      States the indication and the everyday exposures that make it necessary.
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: ULTRA_RARE
  notes: >-
    Consistently described as a rare disease; no reliable population rate is
    quoted in the sources curated here, and the denominator is in any case
    moving as PHOX2B testing identifies milder and later-onset cases. Recorded
    as a qualitative class rather than a fabricated rate.
  evidence:
  - reference: PMID:19712905
    reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      a rare disease defined by the lack of CO(2) responsiveness and of breathing
      automaticity in sleep
    explanation: >-
      Supports the qualitative rarity class; no numeric rate is asserted because
      none is given.
references:
- reference: PMID:20301600
  title: Congenital Central Hypoventilation Syndrome.
  tags:
  - GeneReviews
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    evidence:
    - reference: PMID:19712905
      reference_title: "PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Phox2b is a master regulator of visceral reflex circuits.
      explanation: >-
        A developmental disorder of central autonomic reflex circuitry whose
        respiratory manifestation is secondary to a neural lesion; classified
        under the nervous-system chapter.
discussions:
- discussion_id: gap_rtn_selective_vulnerability
  kind: KNOWLEDGE_GAP
  prompt: >-
    Why are retrotrapezoid nucleus neurons uniquely vulnerable to mutant PHOX2B
    when the protein is required throughout the visceral reflex circuitry?
  attaches_to:
  - pathophysiology#Failed Development of Retrotrapezoid Nucleus Chemoreceptor Neurons
  rationale: >-
    This is the disorder's central unexplained fact and is stated as such in the
    primary literature. PHOX2B is expressed across the central and peripheral
    autonomic nervous system, yet in the mouse model carrying the commonest human
    mutation the retrotrapezoid nucleus is severely depleted and no other
    neuronal loss is detectable. Any account of the disorder that does not
    explain the selectivity is incomplete, and the question is not academic: the
    mutant protein is thought to act through polyalanine aggregation, and whether
    a therapy could rescue the vulnerable population depends on whether its
    vulnerability reflects a cell-intrinsic dependence on PHOX2B dosage, a
    developmental timing window, or a difference in aggregate handling.
  proposed_experiments:
  - experiment_id: exp_rtn_vulnerability_single_cell
    name: Comparative single-cell profiling of vulnerable and spared PHOX2B lineages
    description: >-
      Single-cell transcriptomic and proteomic comparison of retrotrapezoid
      nucleus neurons against spared PHOX2B-dependent populations in
      Phox2b(27Ala/+) and wild-type mice across the developmental window,
      quantifying PHOX2B target-gene dosage dependence and mutant-protein
      aggregate burden per lineage.
- discussion_id: gap_no_therapy_for_chemoreflex
  kind: KNOWLEDGE_GAP
  prompt: >-
    Can central chemoreception be restored pharmacologically, rather than only
    substituted for mechanically?
  attaches_to:
  - pathophysiology#Loss of Central Chemoreflex Response to Hypercapnia and Hypoxaemia
  rationale: >-
    Every treatment curated in this entry acts downstream of the lesion, on
    ventilation rather than on chemoreception, and none is disease-modifying.
    Two lines have been proposed and neither is settled: desogestrel, a
    progestin observed to increase the ventilatory response in isolated cases and
    taken into clinical evaluation, and pharmacological approaches directed at
    the toxic effects of polyalanine-expanded PHOX2B aggregates. Both are
    curated here as open rather than as treatments, because the entry should not
    present investigational agents as options; the reason to record the gap is
    that a partial chemoreflex response would change the disorder's management
    fundamentally, and the conditional mouse model shows partial responses can
    develop.
  proposed_experiments:
  - experiment_id: exp_desogestrel_controlled_ventilatory_response
    name: Controlled assessment of progestin effect on the ventilatory response
    description: >-
      Blinded, placebo-controlled crossover assessment of the hypercapnic
      ventilatory response in adults with congenital central hypoventilation
      syndrome under desogestrel, with genotype stratification, since the
      published observations are uncontrolled and inconsistent across patients.
📚

References & Deep Research

References

1
PMID:20301600
Congenital Central Hypoventilation Syndrome.
No top-level findings curated for this source.